Bacterially expressed truncated F2 domain of Plasmodium falciparum EBA-140 antigen can bind to human erythrocytes

• Autorzy: Rydzak J. , Krynska K. , Suchanowska A. , Kaczmarek R. , Lukasiewicz J. , Czerwinski M. , Jaskiewicz E.
• Języki publikacji: EN

Abstrakty

EN

 The recently identified erythrocyte binding antigen-140 (EBA-140) is a member of the Plasmodium falciparum DBL family of erythrocyte binding proteins, which are considered as prospective candidates for malaria vaccine development. The EBA-140 ligand is a paralogue of the well-characterized P. falciparum EBA-175 antigen. They share homology of domain structure, including Region II, which consists of two homologous F1 and F2 domains and is responsible for ligand-erythrocyte interaction during invasion. It was shown that the F2 domain of EBA-175 antigen seems to be more important for erythrocyte binding. In order to study activity and immunogenicity of EBA-140 antigen F2 domain, it is necessary to obtain recombinant protein of high purity and in a sufficient amount, which used to pose a challenge due to the high content of disulphide bridges. Here, we present a new method for expression and purification of Plasmodium falciparum EBA-140 antigen F2 domain in E. coli Rosetta-gami strain in fusion with the maltose binding protein (MBP). The truncated F2 domain formed by spontaneous proteolytic degradation of the fusion protein was purified by affinity chromatography on Ni-NTA resin followed by size exclusion chromatography. Molecular mass of this protein was confirmed by mass spectrometry. Its N-terminal amino acid sequencing revealed a proteolytic cleavage site within the F2 domain. The proper folding of the recombinant, truncated F2 domain of EBA-140 antigen was confirmed by circular dichroism analysis. The truncated F2 domain can specifically bind to human erythrocytes but its binding is not as efficient as that of full Region II. This confirms that both the F1 and F2 domains of EBA-140 antigen are required for effective erythrocyte binding.

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 2012
• Tom: 59
• Numer: 4
• Opis fizyczny: p.685-691,fig.,ref.

Twórcy

autor

Rydzak J.

• Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

autor

Krynska K.

• Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

autor

Suchanowska A.

• Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

autor

Kaczmarek R.

• Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

autor

Lukasiewicz J.

• Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

autor

Czerwinski M.

• Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

autor

Jaskiewicz E.

• Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

Bibliografia

• Adams JH, Blair PL, Kaneko O, Peterson DS (2001) An expanding ebl family of Plasmodium falciparum. Trends Parasitol 17: 297-299. 
• Baldridge JR, Crane RT (1999) Monophosphoryl lipid A (MPL) formulations for next generation of vaccines. Methods 19: 103-107. 
• Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254. 
• Cowman AF, Crabb BS (2006) Invasion of red blood cells by malaria parasites. Cell 124: 755-766. 
• Czepczyńska-Krężel H, Czerwinski M, Krężel A, Krop-Watorek A (2011) Isolation of carcinoembryonic antigen N-terminal domains (N-A1) from soluble aggregates. Protein Expr Purif 78: 78-85. 
• Ford L, Lobo CA, Rodriguez M, Zalis MG, Machado RL, Rossit AR, Cavasini CE, Couto AA, Enyong PA, Lustigman S (2007) Differential antibody responses to Plasmodium falciparum invasion ligand proteins in individuals living in malaria-endemic areas in Brasil and Camerun. Am J Trop Med Hyg 77: 977-983. 
• Gaur D, Mayer DC, Miller LH (2004) Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites. Int J Parasitol 34: 1413-1429. 
• Gilberger TW, Thompson JK, Triglia T, Good RT, Duraisingh MT, Cowman AF (2003) A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes. J Biol Chem 278: 14480-14486. 
• Greenwood BM, Fidock DA, Kyle DE, Kappe SH, Alonso PL, Collins FH, Duffy PE (2008) Malaria: progress, perils, and prospects for eradication. J Clin Invest 118: 1266-1276. 
• Jaśkiewicz E (1991) Molekularne i genetyczne podstawy układu grupowego Gerbich ludzkich erytrocytów. Postepy Biochem 37: 75-81. 
• Jaśkiewicz E, Jedynak A, Zioło E (2005) Expression of recombinant forms of human 21.5 kDa myelin basic protein and proteolipid protein in CHO cells. Acta Biochim Pol 52: 863-866. 
• Jaśkiewicz E (2007) Glikoforyny ludzkich erytrocytów jako receptory dla zarodźca sierpowego malarii Plasmodium falciparum. Postępy Hig Med Dośw 61: 718-724 (in Polish). 
• Jaśkiewicz E, Graczyk J, Rydzak J (2010) Białka biorące udział w procesie inwazji erytrocytów ludzkich przez zarodźce malarii. Postępy Hig Med Dośw 64: 617-626 (in Polish). 
• Jiang L, Duriseti S, Sun P, Miller LH (2009) Molecular basis of binding of the Plasmodium falciparum receptor BAEBL to erythrocyte receptor glycophorin C. Mol Biochem Parasitol 168: 49-54. 
• Kapust RB, Waugh DS (1999) Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci 8: 1668-1674. 
• Kobayashi K, Kato K, Sugi T, Takemae H, Pandey K, Gong K, Tohya Y, Akashi H (2010) Plasmodium falciparum BAEBL binds to heparan sulfate proteoglycans on the human erythrocyte surface. J Biol Chem 285: 1716-1725. 
• Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685. 
• Lin DH, Malpede BM, Batchelor JD, Tolia NH (2012) Crystal and solution structures of Plasmodium falciparum Erythrocyte Binding Antigen 140 reveal determinants of receptor specificity during erythrocyte invasion. J Biol Chem 287: 36830-3686. 
• Liang H, Narum DL, Fuhrmann SR, Luu T, Sim BK (2000) A recombinant baculovirus-expressed Plasmodium falciparum receptor-binding domain of erythrocyte binding protein EBA-175 biologically mimics native protein. Infect Immunity 68: 3564-3568. 
• Lobo CA, Rodriguez M, Reid M, Lustigman S (2003) Glycophorin C is the receptor for the Plasmodium falciparum erythrocyte binding ligand PfEBP-2 (baebl). Blood 101: 4628-4631. 
• Maier AG, Duraisingh MT, Reeder JC, Patel SS, Kazura JW, Zimmerman PA, Cowman AF (2003) Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat Med 9: 87-92. 
• Mayer DC, Mu JB, Feng X, Su XZ, Miller LH (2002) Polymorphism in a Plasmodium falciparum erythrocyte-binding ligand changes its receptor specificity. J Exp Med 196: 1523-1528. 
• Narum DL, Fuhrmann SR, Luu T, Sim BK (2002) A novel Plasmodium falciparum erythrocyte binding protein (EBP2/BAEBL) involved in erythrocyte receptor binding. Mol Biochem Parasitol 119: 159-168. 
• Ockenhouse CF, Barbosa A, Blackall DP, Murphy CI, Kashala O, Dutta S, Lanar DE, Daugherty JR (2001) Sialic acid-dependent binding of baculovirus-expessed recombinant antigens from Plasmodium falciparum EBA-175 to glycophorin A. Mol Biochem Parasitol 113: 9-21. 
• Pandey KC, Singh S, Pattnaik P, Pillai CR, Lynn A, Chitnis CE (2002) Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies. Mol Biochem Parasitol 123: 23-33. 
• Pierce SK, Miller LH (2009) World Malaria Day 2009: what Malaria knows about the immune system that immunologists still do not. J Immunol 182: 5171-5177. 
• Sim BK, Chitnis CE, Wasniowska K, Hadley TJ, Miller LH (1994) Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparu. Science 264: 1941-1944. 
• Stewart EJ, Aslund F, Beckwith J (1998) Disulfide bond formation in the Escherichia coli cytoplasm: an in vivo role reversal for the thioredoxins. EMBO J 17: 5543-5550. 
• Thompson JK, Triglia T, Reed MB, Cowman AF (2001) A novel ligand from Plasmodium falciparum that binds to a sialic acid-containing receptor on the surface of human erythrocytes. Mol Microbiol 41: 47-58. 
• Tolia NH, Enemark EJ, Sim BK, Joshua-Tor L (2005) Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. Cell 122: 183-193. 
• Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354. 
• Villaverde A, Carrió MM (2003) Protein aggregation in recombinant bacteria: biological role of inclusion bodies. Biotechnol Lett 25: 1385-1395. 
• Yadava A, Ockenhouse CF (2003) Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems. Infect Immun 71: 4961-4969. 
• Zhang D, Pan W (2005) Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood stage parasites. Infec Immunity 73: 6530-6536. 

Uwagi

rekord w opracowaniu